Quaker Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236 Buy
2
+1
+100% +$140 ﹤0.01% 858
2025
Q4
$164 Hold
1
﹤0.01% 889
2025
Q3
$134 Sell
1
-1
-50% -$121 ﹤0.01% 805
2025
Q2
$249 Buy
+2
New +$255 ﹤0.01% 773

Other funds holding RGEN

Quaker Wealth Management's RGEN Position: Q1 2026 in Review

Quaker Wealth Management increased its Repligen (RGEN) stake by 100% in Q1 2026, buying an estimated $140 and bringing the position to 2 shares worth $236. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Quaker Wealth Management first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $249 in Q2 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Quaker Wealth Management held 2 shares of Repligen worth $236 as of Q1 2026.
  • Quaker Wealth Management bought 1 Repligen share in Q1 2026, an estimated $140.
  • Repligen made up ﹤0.01% of Quaker Wealth Management's portfolio in Q1 2026, its #858 holding.
  • Quaker Wealth Management first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
  • Quaker Wealth Management's Repligen position peaked at $249 in Q2 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.